• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉内暴露于低剂量低传代或细胞培养适应的苏丹病毒或埃博拉病毒。

Intramuscular Exposure of to Low Doses of Low Passage- or Cell Culture-Adapted Sudan Virus or Ebola Virus.

机构信息

Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio, TX 78227, USA.

Current Affiliation: Graduate School of Biomedical Sciences, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

出版信息

Viruses. 2018 Nov 16;10(11):642. doi: 10.3390/v10110642.

DOI:10.3390/v10110642
PMID:30453499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6267154/
Abstract

The filoviruses Ebola virus (EBOV) and Sudan virus (SUDV) can cause severe diseases, and there are currently no licensed countermeasures available for use against them. Transmission occurs frequently via contact with bodily fluids from infected individuals. However, it can be difficult to determine when or how someone became infected, or the quantity of infectious virus to which they were exposed. Evidence suggests the infectious dose is low, but the majority of published studies use high exposure doses. This study characterized the outcome of exposure to a low dose of EBOV or SUDV, using a model. Further, because the effect of virus passage in cell culture may be more pronounced when lower exposure doses are used, viruses that possessed either the characteristics of wild type viruses (possessing predominantly 7-uridine (7U) genotype and a high particle-to-plaque forming unit (PFU) ratio) or cell culture-passaged viruses (predominantly 8-uridine (8U) genotype, a lower particle-to-PFU ratio) were used. The time to death after a low dose exposure was delayed in comparison to higher exposure doses. These data demonstrated that an extremely low dose of EBOV or SUDV is sufficient to cause lethal disease. A low dose exposure model can help inform studies on pathogenesis, transmission, and optimization of prevention strategies.

摘要

丝状病毒埃博拉病毒(EBOV)和苏丹病毒(SUDV)可引起严重疾病,目前尚无针对它们的许可对策。传播通常通过接触受感染者的体液发生。然而,很难确定某人何时或如何感染,或接触到的传染性病毒的数量。有证据表明感染剂量很低,但大多数已发表的研究都使用高暴露剂量。本研究使用模型来描述接触低剂量 EBOV 或 SUDV 的后果。此外,由于当使用较低的暴露剂量时,病毒在细胞培养中的传代可能更明显,因此使用具有野生型病毒特征(主要具有 7-尿嘧啶(7U)基因型和高粒子到空斑形成单位(PFU)比)或细胞培养传代病毒(主要是 8-尿嘧啶(8U)基因型,粒子到 PFU 比低)的病毒。与高暴露剂量相比,低剂量暴露后死亡的时间延迟。这些数据表明,极低剂量的 EBOV 或 SUDV 足以引起致命疾病。低剂量暴露模型可以帮助了解发病机制、传播以及预防策略的优化研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4973/6267154/792a12e75385/viruses-10-00642-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4973/6267154/0f25d817f2d7/viruses-10-00642-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4973/6267154/34c2183359f6/viruses-10-00642-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4973/6267154/ae3f066d4e15/viruses-10-00642-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4973/6267154/f0eb4e5a8bbd/viruses-10-00642-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4973/6267154/50f9ce4cae03/viruses-10-00642-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4973/6267154/792a12e75385/viruses-10-00642-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4973/6267154/0f25d817f2d7/viruses-10-00642-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4973/6267154/34c2183359f6/viruses-10-00642-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4973/6267154/ae3f066d4e15/viruses-10-00642-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4973/6267154/f0eb4e5a8bbd/viruses-10-00642-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4973/6267154/50f9ce4cae03/viruses-10-00642-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4973/6267154/792a12e75385/viruses-10-00642-g006.jpg

相似文献

1
Intramuscular Exposure of to Low Doses of Low Passage- or Cell Culture-Adapted Sudan Virus or Ebola Virus.肌肉内暴露于低剂量低传代或细胞培养适应的苏丹病毒或埃博拉病毒。
Viruses. 2018 Nov 16;10(11):642. doi: 10.3390/v10110642.
2
Particle-to-PFU ratio of Ebola virus influences disease course and survival in cynomolgus macaques.埃博拉病毒的颗粒与蚀斑形成单位比率影响食蟹猴的病程和存活情况。
J Virol. 2015 Jul;89(13):6773-81. doi: 10.1128/JVI.00649-15.
3
Development and Characterization of a Guinea Pig-Adapted Sudan Virus.一种豚鼠适应株苏丹病毒的研制与特性分析
J Virol. 2015 Oct 21;90(1):392-9. doi: 10.1128/JVI.02331-15. Print 2016 Jan 1.
4
Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus.非人灵长类动物经口和结膜暴露于低剂量的埃博拉病毒马科纳株。
J Infect Dis. 2016 Oct 15;214(suppl 3):S263-S267. doi: 10.1093/infdis/jiw149. Epub 2016 Jun 9.
5
Natural history of infection in rhesus and cynomolgus macaques.恒河猴和食蟹猴感染的自然史。
Emerg Microbes Infect. 2022 Dec;11(1):1635-1646. doi: 10.1080/22221751.2022.2086072.
6
Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain.感染埃博拉病毒马科纳毒株的食蟹猴疾病进展延迟
Emerg Infect Dis. 2015 Oct;21(10):1777-83. doi: 10.3201/eid2110.150259.
7
Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.基于痘病毒的埃博拉病毒表达 GP 和 VP40 蛋白疫苗候选物的免疫原性和疗效的差异。
J Virol. 2018 May 14;92(11). doi: 10.1128/JVI.00363-18. Print 2018 Jun 1.
8
Ebola virus transmission in guinea pigs.埃博拉病毒在豚鼠中的传播。
J Virol. 2015 Jan 15;89(2):1314-23. doi: 10.1128/JVI.02836-14. Epub 2014 Nov 12.
9
Natural history of nonhuman primates after conjunctival exposure to Ebola virus.非人类灵长类动物在结膜暴露于埃博拉病毒后的自然史。
Sci Rep. 2023 Mar 13;13(1):4175. doi: 10.1038/s41598-023-31027-7.
10
Interferon α/β Receptor-Deficient Mice as a Model for Ebola Virus Disease.α/β干扰素受体缺陷小鼠作为埃博拉病毒病的模型
J Infect Dis. 2015 Oct 1;212 Suppl 2:S282-94. doi: 10.1093/infdis/jiv215. Epub 2015 May 4.

引用本文的文献

1
Remdesivir, mAb114, REGN-EB3, and ZMapp partially rescue nonhuman primates infected with a low passage Kikwit variant of Ebola virus.瑞德西韦、mAb114、REGN-EB3和ZMapp可部分挽救感染低代次基奎特埃博拉病毒变种的非人灵长类动物。
Nat Commun. 2025 Apr 23;16(1):3824. doi: 10.1038/s41467-025-59168-5.
2
Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control.新发和再发传染病:全球趋势及预防和控制新策略。
Signal Transduct Target Ther. 2024 Sep 11;9(1):223. doi: 10.1038/s41392-024-01917-x.
3
Natural History of Nonhuman Primates After Oral Exposure to Ebola Virus Variant Makona.

本文引用的文献

1
A Single Amino Acid Change in the Marburg Virus Glycoprotein Arises during Serial Cell Culture Passages and Attenuates the Virus in a Macaque Model of Disease.在连续细胞培养传代过程中,马尔堡病毒糖蛋白发生单个氨基酸变化,并在猕猴疾病模型中使病毒减毒。
mSphere. 2018 Jan 3;3(1). doi: 10.1128/mSphere.00401-17. eCollection 2018 Jan-Feb.
2
Development of a Lethal Intranasal Exposure Model of Ebola Virus in the Cynomolgus Macaque.在食蟹猴中建立致命性鼻腔内暴露感染埃博拉病毒模型。
Viruses. 2017 Oct 29;9(11):319. doi: 10.3390/v9110319.
3
Pathogenicity Comparison Between the Kikwit and Makona Ebola Virus Variants in Rhesus Macaques.
食蟹猴经口暴露于埃博拉病毒变异株 Makona 后的自然史。
J Infect Dis. 2023 Nov 13;228(Suppl 7):S571-S581. doi: 10.1093/infdis/jiad225.
4
Natural history of nonhuman primates after conjunctival exposure to Ebola virus.非人类灵长类动物在结膜暴露于埃博拉病毒后的自然史。
Sci Rep. 2023 Mar 13;13(1):4175. doi: 10.1038/s41598-023-31027-7.
5
Development of a Well-Characterized Cynomolgus Macaque Model of Sudan Virus Disease for Support of Product Development.开发一种特征明确的用于支持产品研发的苏丹病毒病食蟹猴模型。
Vaccines (Basel). 2022 Oct 15;10(10):1723. doi: 10.3390/vaccines10101723.
6
On-Demand Patient-Specific Phenotype-to-Genotype Ebola Virus Characterization.按需患者特异性表型至基因型埃博拉病毒特征描述。
Viruses. 2021 Oct 6;13(10):2010. doi: 10.3390/v13102010.
7
Identification and Characterization of Defective Viral Genomes in Ebola Virus-Infected Rhesus Macaques.鉴定和分析埃博拉病毒感染恒河猴缺陷型病毒基因组。
J Virol. 2021 Aug 10;95(17):e0071421. doi: 10.1128/JVI.00714-21.
8
Opportunities for Refinement of Non-Human Primate Vaccine Studies.改进非人灵长类动物疫苗研究的机会。
Vaccines (Basel). 2021 Mar 19;9(3):284. doi: 10.3390/vaccines9030284.
9
Pathogenicity and Virulence of Ebolaviruses with Species- and Variant-specificity.埃博拉病毒的物种和变体特异性的致病性和毒力。
Virulence. 2021 Dec;12(1):885-901. doi: 10.1080/21505594.2021.1898169.
10
Development of a Well-Characterized Rhesus Macaque Model of Ebola Virus Disease for Support of Product Development.开发一种特征明确的埃博拉病毒病恒河猴模型以支持产品研发。
Microorganisms. 2021 Feb 26;9(3):489. doi: 10.3390/microorganisms9030489.
恒河猴中基奎特和马科纳埃博拉病毒变体的致病性比较
J Infect Dis. 2016 Oct 15;214(suppl 3):S281-S289. doi: 10.1093/infdis/jiw267. Epub 2016 Sep 19.
4
Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus.非人灵长类动物经口和结膜暴露于低剂量的埃博拉病毒马科纳株。
J Infect Dis. 2016 Oct 15;214(suppl 3):S263-S267. doi: 10.1093/infdis/jiw149. Epub 2016 Jun 9.
5
Persistence of Ebola virus in various body fluids during convalescence: evidence and implications for disease transmission and control.埃博拉病毒在康复期各种体液中的持续存在:对疾病传播和控制的证据及影响
Epidemiol Infect. 2016 Jun;144(8):1652-60. doi: 10.1017/S0950268816000054. Epub 2016 Jan 25.
6
Recurrence and reinfection--a new paradigm for the management of Ebola virus disease.复发与再感染——埃博拉病毒病管理的新范式
Int J Infect Dis. 2016 Feb;43:58-61. doi: 10.1016/j.ijid.2015.12.011. Epub 2015 Dec 19.
7
Ebola Virus Infections in Nonhuman Primates Are Temporally Influenced by Glycoprotein Poly-U Editing Site Populations in the Exposure Material.非人灵长类动物中的埃博拉病毒感染受到暴露材料中糖蛋白多聚-U编辑位点群体的时间影响。
Viruses. 2015 Dec 19;7(12):6739-54. doi: 10.3390/v7122969.
8
Determination and Therapeutic Exploitation of Ebola Virus Spontaneous Mutation Frequency.埃博拉病毒自发突变频率的测定与治疗性利用
J Virol. 2015 Dec 16;90(5):2345-55. doi: 10.1128/JVI.02701-15.
9
Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.埃博拉病毒和马尔堡病毒感染非人灵长类动物模型使用中的注意事项。
J Infect Dis. 2015 Oct 1;212 Suppl 2(Suppl 2):S91-7. doi: 10.1093/infdis/jiv284. Epub 2015 Jun 10.
10
Genetic Changes at the Glycoprotein Editing Site Associated With Serial Passage of Sudan Virus.与苏丹病毒连续传代相关的糖蛋白编辑位点的基因变化
J Infect Dis. 2015 Oct 1;212 Suppl 2(Suppl 2):S295-304. doi: 10.1093/infdis/jiv216. Epub 2015 Apr 28.